BIOLATTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 6.223
EU - Europa 3.856
AS - Asia 3.710
SA - Sud America 441
AF - Africa 157
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.452
Nazione #
US - Stati Uniti d'America 6.078
IT - Italia 1.562
SG - Singapore 1.310
CN - Cina 1.003
DE - Germania 380
IE - Irlanda 346
BR - Brasile 344
GB - Regno Unito 289
SE - Svezia 280
VN - Vietnam 220
IN - India 204
KR - Corea 197
JP - Giappone 183
FR - Francia 169
FI - Finlandia 152
AT - Austria 129
HK - Hong Kong 113
ID - Indonesia 99
UA - Ucraina 98
CA - Canada 95
PL - Polonia 78
SA - Arabia Saudita 73
NL - Olanda 69
AU - Australia 51
BE - Belgio 49
IQ - Iraq 49
TR - Turchia 49
ES - Italia 45
IR - Iran 43
MX - Messico 40
GR - Grecia 38
RU - Federazione Russa 35
IL - Israele 33
PK - Pakistan 31
TW - Taiwan 31
SN - Senegal 30
ZA - Sudafrica 30
AR - Argentina 27
CO - Colombia 27
DK - Danimarca 27
ET - Etiopia 25
BD - Bangladesh 23
UG - Uganda 18
CH - Svizzera 16
NO - Norvegia 16
MA - Marocco 14
EC - Ecuador 13
NZ - Nuova Zelanda 13
RO - Romania 12
TN - Tunisia 12
PE - Perù 11
LT - Lituania 10
SI - Slovenia 10
PH - Filippine 9
CZ - Repubblica Ceca 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
JO - Giordania 6
KE - Kenya 6
MY - Malesia 6
VE - Venezuela 6
CL - Cile 5
EG - Egitto 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
NG - Nigeria 4
PR - Porto Rico 4
RS - Serbia 4
LU - Lussemburgo 3
NP - Nepal 3
PA - Panama 3
UY - Uruguay 3
ZM - Zambia 3
AL - Albania 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GY - Guiana 2
HU - Ungheria 2
IS - Islanda 2
PY - Paraguay 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
EU - Europa 1
GH - Ghana 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
Totale 14.447
Città #
Chandler 849
Singapore 757
Ashburn 524
Santa Clara 402
Dublin 339
Beijing 328
Dallas 250
Turin 247
Torino 205
Fairfield 180
Los Angeles 145
Ann Arbor 134
Houston 134
Seoul 122
Hefei 117
Woodbridge 116
Sovicille 115
Nyköping 114
Vienna 111
Columbus 107
Seattle 104
Munich 102
Redwood City 100
Jakarta 97
Jacksonville 91
Wilmington 85
Cambridge 81
Princeton 81
New York 76
Guangzhou 73
Medford 73
Pisa 71
Milan 69
Dong Ket 65
Dearborn 62
Rome 62
Warsaw 61
Villeurbanne 59
Tokyo 54
Boston 52
Buffalo 48
Bengaluru 46
Ho Chi Minh City 45
Fremont 44
Turku 44
Boardman 42
Frankfurt am Main 42
Hong Kong 41
Jeddah 41
Lappeenranta 38
São Paulo 37
Redondo Beach 33
Washington 33
Brusasco 32
Mumbai 31
Hanoi 29
Shanghai 28
Norwalk 26
Addis Ababa 25
Helsinki 25
Higashiayase 25
London 25
Hebei 24
Cardiff 23
San Diego 23
Denver 22
Maddaloni 22
Stockholm 22
Taipei 22
Toronto 22
Birmingham 21
Nanjing 21
Pittsburgh 21
Rochester 21
Atlanta 19
Brussels 19
Chennai 19
Genoa 19
Wuhan 19
Florence 18
Kampala 18
New Delhi 18
Nuremberg 18
Elk Grove Village 17
Hanover 17
Johannesburg 17
Melbourne 17
Bogotá 16
Chicago 16
Hangzhou 16
Manchester 16
San Mauro Torinese 16
Gongju 15
Hyderabad 15
Phoenix 15
Lahore 14
Novara 14
Sulaymaniyah 14
Ta'if 14
Thebes 14
Totale 8.288
Nome #
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 475
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 368
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 366
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 323
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 288
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 269
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. 267
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 231
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 219
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 214
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 209
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 209
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 208
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 202
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 200
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 199
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 197
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 197
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 191
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 187
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 170
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 170
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 169
Strigolactone analogs are promising antiviral agents against Herpesviruses 169
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 166
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 161
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 156
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 151
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 150
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 149
A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. 148
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 147
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 145
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 145
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 144
Past and ongoing adaptation of human cytomegalovirus to its host. 144
Where do we stand after decades of studying human cytomegalovirus? 143
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 141
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 139
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 136
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 136
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 136
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 133
Tuning the Orchestra: HCMV vs. Innate Immunity. 131
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 126
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 126
Risk of Symptomatic Infection after Non-Primary Congenital Cytomegalovirus Infection 124
Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses [*Valentina Dell'Oste, Daniele Castagnolo: co-corresponding authors] 123
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 122
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 118
45th International Herpesvirus Workshop 118
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 117
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 115
50° Congresso Nazionale della Società Italiana di Microbiologia 112
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 112
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 110
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 109
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 109
Antimicrobial Efficacy of a Vegetable Oil Plasticizer in PVC Matrices 108
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 108
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 107
Exploring the urinary metabolomic fingerprint of human cytomegalovirus: a 1H-NMR study on congenitally infected newborns 107
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 106
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ 103
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 102
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 102
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 101
HERPES SIMPLEX VIRUS TYPE 1 EXPLOITS LIPID METABOLISM: IMPLICATIONS FOR VIRAL INFECTIVITY AND ALZHEIMER’S DISEASE 100
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 99
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 99
Targeting PAD-mediated citrullination to treat human papillomavirus infections 99
PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma 94
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 93
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 93
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 93
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 93
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 93
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 92
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 90
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 89
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 88
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 86
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 84
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 82
Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection 82
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 82
1H NMR Urinary Metabolomics Profiling of Newborns with Congenital Human Cytomegalovirus Infection: Insights into Metabolic Alterations 79
THE GENETIC VARIABILITY OF HUMAN CITOMEGALOVIRUS: POSSIBLE IMPLICATIONS IN CLINICAL, IMMUNOLOGICAL AND VIROLOGICAL SETTINGS 79
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 79
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 78
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 77
CONGENITAL CYTOEGALOVIRUS INFECTION: CAN THE DIFFERENCE BETWEEN THE VIRUS’ RELATIONSHIP WITH THE HOST’S IMMUNE SYSTEM EXPLAIN THE DIFFERENCE IN CLINICAL PHENOTYPES? 77
STRIGOLACTONES FOR USE IN PREVENTING AND/OR TREATING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY 71
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 69
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 68
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 68
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 66
Antiherpetic Activity of Imiquimod-Based Ruthenium Metal Complexes 64
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 64
La variabilità genetica del citomegalovirus umano: possibili implicazioni dal punto di vista clinico, immunologico e virologico 64
Totale 13.917
Categoria #
all - tutte 43.316
article - articoli 0
book - libri 0
conference - conferenze 26.481
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021901 0 0 0 0 97 118 132 75 84 152 67 176
2021/20221.294 75 71 91 128 70 54 61 69 45 92 324 214
2022/20232.390 130 143 56 279 255 537 118 211 323 71 138 129
2023/20241.350 167 164 95 62 122 161 100 92 24 102 95 166
2024/20253.353 109 311 295 287 558 256 202 171 204 184 312 464
2025/20262.906 723 409 472 889 413 0 0 0 0 0 0 0
Totale 14.740